Story perspectives

Genetic Tests Predict Weight Loss Drug Responses

9/19/2025

30 7

Summary

Story summary

Researchers are examining weight loss drugs like semaglutide to predict responses through genetic tests related to calorie satiation.
The study in Cell Metabolism involved nearly 800 adults and found significant variations in calorie intake.
A new metric, the Calories to Satiation Genetic Risk Score (CTS-GRS), estimates individual satiation thresholds.
GLP-1 medications, such as Ozempic, may alter taste perception, with over 21% of participants reporting increased sweetness and nearly 23% noting heightened saltiness.
These taste changes relate to weight loss satisfaction and reduced cravings, warranting further research on underlying mechanisms.

1 of 1

Story summary

Researchers are examining weight loss drugs like semaglutide to predict responses through genetic tests related to calorie satiation.
The study in Cell Metabolism involved nearly 800 adults and found significant variations in calorie intake.
A new metric, the Calories to Satiation Genetic Risk Score (CTS-GRS), estimates individual satiation thresholds.
GLP-1 medications, such as Ozempic, may alter taste perception, with over 21% of participants reporting increased sweetness and nearly 23% noting heightened saltiness.
These taste changes relate to weight loss satisfaction and reduced cravings, warranting further research on underlying mechanisms.